About Impladent
Impladent is a company based in Valley Stream (United States) founded in 2002 was acquired by SolmeteX in June 2023. Impladent offers products and services including OsteoGen Plugs, OsteoGen Strips, CollaForm, TriStar Bone Graft Fixation System, and OsteoFlex Membrane. Impladent operates in a competitive market with competitors including Theradaptive, Aziyo Biologics, MiMedx Group, Ossio and RevBio, among others.
- Headquarter Valley Stream, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Impladent Ltd
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Impladent
Impladent offers a comprehensive portfolio of products and services, including OsteoGen Plugs, OsteoGen Strips, CollaForm, TriStar Bone Graft Fixation System, and OsteoFlex Membrane.
Combined graft and collagen plug for dental socket preservation.
Resorbable collagen strips for dental bone regeneration.
Absorbable collagen for tissue and graft maintenance.
Screws for secure bone graft fixation in dental procedures.
Flexible resorbable membrane for dental bone grafting support.
Funding Insights of Impladent
Detailed funding history for Impladent
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Impladent
Impladent has secured backing from 1 investor. Prominent investors backing the company include SolmeteX.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of water management solutions for dental practices
|
Locked | Locked | Locked |
Investor details for Impladent
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Impladent
Investment portfolio details for Impladent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Impladent
Detailed financials for Impladent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Impladent Comparisons
Peer comparison for Impladent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Impladent
Impladent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theradaptive, Aziyo Biologics, MiMedx Group, Ossio and RevBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| Locked | Locked | Locked |
Synthetic adhesives for bone and dental repair are developed.
|
|
| Locked | Locked | Locked |
Developer of stem cells to regrow damaged bones
|
Detailed competitors of Impladent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Impladent
Complete news archive for Impladent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Impladent
Impladent was founded in 2002.
Impladent is headquartered in Valley Stream, United States. It is registered at Valley Stream, New York, United States.
Impladent develops a range of regenerative materials including bone graft products and resorbable membranes. Products developed by the company includes OsteoGen synthetic bioactive resorbable graft for bone augmentation and repair of alveolar defects; OsteoGen non-ceramic crystals - equivalent to the human trabecular bone making this product a pure alloplast; OsteoGen bone grafting plugs - solution for socket preservation without the need for a membrane; and OsteoGen Plug combines bone graft with a bovine achilles tendon carrier to graft the extraction sites.
Impladent's top competitors include EpiBone, Theradaptive and MiMedx Group.
Impladent offers OsteoGen Plugs, OsteoGen Strips, CollaForm, TriStar Bone Graft Fixation System, and OsteoFlex Membrane.
Impladent has 1 investor. Key investors include SolmeteX.